Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
Palo Alto Networks
PANW
|
+$957M |
| 3 |
Medtronic
MDT
|
+$433M |
| 4 |
Pinterest
PINS
|
+$422M |
| 5 |
Colgate-Palmolive
CL
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$967M |
| 3 |
Apple
AAPL
|
+$847M |
| 4 |
Meta Platforms (Facebook)
META
|
+$700M |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$576M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 7.33% |
| 3 | Healthcare | 6.04% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Communication Services | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Instil Bio
TIL
$50.3M
| $16K | ﹤0.01% |
175
-264
| -60% | -$37.4K |
|
4302
Tejon Ranch
TRC
$451M
| $16K | ﹤0.01% |
1,044
-2,439
| -70% | -$42.1K |
|
4303
Verastem
VSTM
$610M
| $16K | ﹤0.01% |
1,187
-2,319
| -66% | -$36.9K |
|
4304
Willdan Group
WLDN
$1.3B
| $16K | ﹤0.01% |
582
-4,916
| -89% | -$134K |
|
|
BVH
4305
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $16K | ﹤0.01% |
643
-1,683
| -72% | -$44.5K |
|
|
INDT
4306
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $16K | ﹤0.01% |
268
-668
| -71% | -$44.4K |
|
4307
Arbutus Biopharma
ABUS
$915M
| $15K | ﹤0.01% |
5,420
-329,376
| -98% | -$843K |
|
|
AEVA
4308
Aeva Technologies
AEVA
$1.86B
| $15K | ﹤0.01% |
972
-2,548
| -72% | -$42K |
|
4309
Aemetis
AMTX
$124M
| $15K | ﹤0.01% |
3,140
-1,250
| -28% | -$10.9K |
|
4310
Sierra Bancorp
BSRR
$525M
| $15K | ﹤0.01% |
689
-1,590
| -70% | -$35.5K |
|
4311
Caribou Biosciences
CRBU
$164M
| $15K | ﹤0.01% |
2,709
-5,660
| -68% | -$43.3K |
|
4312
Primis Financial Corp
FRST
$404M
| $15K | ﹤0.01% |
1,112
-2,807
| -72% | -$37.7K |
|
4313
Ramaco Resources Class A
METC
$649M
| $15K | ﹤0.01% |
+1,163
| New | +$17.5K |
|
|
DFTX
4314
Definium Therapeutics
DFTX
$6.12B
| $15K | ﹤0.01% |
1,520
-1,965
| -56% | -$24.9K |
|
4315
Direxion Daily Homebuilders & Supplies Bull 3X ETF
NAIL
$626M
| $15K | ﹤0.01% |
594
+510
| +607% | +$17.6K |
|
4316
NWPX Infrastructure Inc
NWPX
$1.15B
| $15K | ﹤0.01% |
498
-1,086
| -69% | -$32.2K |
|
4317
Oppenheimer Holdings
OPY
$1.2B
| $15K | ﹤0.01% |
442
-1,058
| -71% | -$36.3K |
|
4318
Ranpak Holdings
PACK
$473M
| $15K | ﹤0.01% |
2,180
-4,106
| -65% | -$52.9K |
|
4319
Rimini Street
RMNI
$471M
| $15K | ﹤0.01% |
2,443
-5,011
| -67% | -$29.8K |
|
4320
RxSight
RXST
$260M
| $15K | ﹤0.01% |
1,033
-1,819
| -64% | -$24K |
|
4321
Latham Group
SWIM
$880M
| $15K | ﹤0.01% |
2,206
-5,062
| -70% | -$53.8K |
|
4322
Utah Medical Products
UTMD
$225M
| $15K | ﹤0.01% |
173
-385
| -69% | -$32.8K |
|
|
TTCF
4323
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
| $15K | ﹤0.01% |
2,457
-6,599
| -73% | -$52.6K |
|
4324
Amalgamated Financial
AMAL
$1.49B
| $14K | ﹤0.01% |
707
-1,570
| -69% | -$30.3K |
|
|
AMRN
4325
Amarin Corp
AMRN
$303M
| $14K | ﹤0.01% |
475
-5
| -1% | -$216 |
|
Similar funds
Barclays's Q2 2022 Portfolio in Review
As of Q2 2022, Barclays held 5,544 positions worth $163B, up 28% from $128B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Barclays deployed $63.1B of net new capital in Q2 2022, opening 560 new positions and adding to 1,332 existing holdings. Its largest new stake was Fisker Inc.: 3,607,227 shares worth $30.9M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.38B trimmed.
- Barclays's largest Q2 2022 buy was Fisker Inc.: 3,607,227 shares worth $30.9M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q2 2022, an estimated $1.04B increase.
- Barclays's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.38B.
- Barclays fully exited Cerner Corp in Q2 2022, selling an estimated $432M.
- Barclays's ten largest holdings make up 39% of its $163B portfolio in Q2 2022.
- Barclays opened 560 new positions and closed 413 in Q2 2022.
- Barclays's portfolio value rose 28% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.